Literature DB >> 34690602

Perimenopause and First-Onset Mood Disorders: A Closer Look.

Natalie Musial1, Zinnia Ali1, Jennifer Grbevski1, Ashan Veerakumar1, Priya Sharma1.   

Abstract

Perimenopause is often a time of social, emotional, and physical change. Various factors contribute to the development of mood disorders during this time. There is a known association among women with previous history of major depressive disorder or bipolar disorder and relapse during the menopausal transition. First-onset mood disorders during this time have been less studied. A literature review in PsycInfo Ovid of records pertaining to first-onset mood disorders during perimenopause showed that this multifactorial process involves hormonal fluctuations, with estrogen being a key player. In addition, vasomotor symptoms, previous negative life events, and socioeconomic status were found to contribute to first-onset mood disorders during perimenopause. Treatment options include established medication regimens for psychiatric conditions; however, hormone therapy also has proven beneficial for this patient population. Further research, particularly on bipolar disorder, is needed to develop a clear association between perimenopause and first-onset mood disorders.
Copyright © 2021 by the American Psychiatric Association.

Entities:  

Keywords:  Depression; bipolar; hormone; perimenopause

Year:  2021        PMID: 34690602      PMCID: PMC8475932          DOI: 10.1176/appi.focus.20200041

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  53 in total

Review 1.  Menopausal Symptoms and Their Management.

Authors:  Nanette Santoro; C Neill Epperson; Sarah B Mathews
Journal:  Endocrinol Metab Clin North Am       Date:  2015-09       Impact factor: 4.741

2.  Hysterectomy and incidence of depressive symptoms in midlife women: the Australian Longitudinal Study on Women's Health.

Authors:  L Wilson; N Pandeya; J Byles; G Mishra
Journal:  Epidemiol Psychiatr Sci       Date:  2017-02-13       Impact factor: 6.892

Review 3.  Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis.

Authors:  James M Whedon; Anupama KizhakkeVeettil; Nancy A Rugo; Kelly A Kieffer
Journal:  J Womens Health (Larchmt)       Date:  2016-09-07       Impact factor: 2.681

Review 4.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.

Authors:  Glenda M MacQueen; Benicio N Frey; Zahinoor Ismail; Natalia Jaworska; Meir Steiner; Ryan J Van Lieshout; Sidney H Kennedy; Raymond W Lam; Roumen V Milev; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

5.  Risk factors for major depression during midlife among a community sample of women with and without prior major depression: are they the same or different?

Authors:  J T Bromberger; L Schott; H M Kravitz; H Joffe
Journal:  Psychol Med       Date:  2014-11-24       Impact factor: 7.723

6.  Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography.

Authors:  Paraskevi Vivien Rekkas; Alan A Wilson; Vivian Wai Han Lee; Priyanga Yogalingam; Julia Sacher; Pablo Rusjan; Sylvain Houle; Donna E Stewart; Nathan J Kolla; Stephen Kish; Lina Chiuccariello; Jeffrey H Meyer
Journal:  JAMA Psychiatry       Date:  2014-08       Impact factor: 21.596

7.  Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.

Authors:  Anita H Clayton; Susan G Kornstein; Boadie W Dunlop; Kristen Focht; Jeff Musgnung; Tanya Ramey; Weihang Bao; Philip T Ninan
Journal:  J Clin Psychiatry       Date:  2013-10       Impact factor: 4.384

8.  Alterations in white matter fractional anisotropy in subsyndromal perimenopausal depression.

Authors:  Xianglan Wang; Jiong Tao; Lingjiang Li; Zhiyong Zhong; Sha Liu; Tianzi Jiang; Jinbei Zhang
Journal:  BMC Psychiatry       Date:  2014-12-24       Impact factor: 3.630

9.  Symptom severity of bipolar disorder during the menopausal transition.

Authors:  Wendy K Marsh; Bernice Gershenson; Anthony J Rothschild
Journal:  Int J Bipolar Disord       Date:  2015-08-22

10.  Risk of Psychiatric Disorders Following Symptomatic Menopausal Transition: A Nationwide Population-Based Retrospective Cohort Study.

Authors:  Li-Yu Hu; Cheng-Che Shen; Jeng-Hsiu Hung; Pan-Ming Chen; Chun-Hsien Wen; Yung-Yen Chiang; Ti Lu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.